Gastrointestinal malignancies in Zambia: a scoping review

Pharidah Rajan Ibrahim Omar Sundi, A. Asombang, Nkengeh N. Tazinkeng, Lisa Liang Philpotts, A. Adekunle, Rodrigue Ndabashinze
{"title":"Gastrointestinal malignancies in Zambia: a scoping review","authors":"Pharidah Rajan Ibrahim Omar Sundi, A. Asombang, Nkengeh N. Tazinkeng, Lisa Liang Philpotts, A. Adekunle, Rodrigue Ndabashinze","doi":"10.55320/mjz.50.3.400","DOIUrl":null,"url":null,"abstract":"Background \nGastrointestinal (GI) malignancies account for greater than one-third of cancer-related deaths worldwide. In Zambia, there is a lack of data on epidemiology, diagnosis, management, and outcomes. We sought to review existing literature to determine the extent of research and identify gaps in knowledge pertaining to GI malignancies in Zambia. \nMethods \nWe systematically searched databases including Ovid MEDLINE, CINAHL, Web of Science Core Collection, Cochrane Library via Ovid, Embase, Africa Wide Information via Ebsco, African Index Medicus and African Journals Online, to identify studies on GI malignancies including colorectal (CRC), pancreatic (PC), gastric (GC), esophageal (EC) and liver cancers (LC) in Zambia.  \nResults \nOf 323 studies screened, 27 were included in the final analysis. The included studies assessed an individual GI cancer or more than one GI cancer as follows: GC only (n=10, 37%), EC only (n=5, 18%), LC only (n=5, 18%), CRC only (n=2, 7%), PC only (n=1, 4%), PC, CRC, EC, GC, LC combined (n=1, 4%), CRC, EC, GC, LC combined (n=1, 4%), CRC, EC, GC combined (n=1, 4%) and EC, GC combined (n=1, 4%). Gastric cancer was the most studied (n =14 articles), followed by esophageal (n=9 articles), liver cancer (n=7 articles), colorectal (n=5 articles) and pancreatic cancer (n=2 articles).  \nConclusion \nThere is paucity of published data. Existing studies have focused mainly on prevalence and risk factors. Longitudinal studies examining incidence, prognosis and survival are needed.  \n  \nKeywords: Gastrointestinal cancer, Zambia, risk factors, management, clinical outcomes. \n ","PeriodicalId":74149,"journal":{"name":"Medical journal of Zambia","volume":"218 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical journal of Zambia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55320/mjz.50.3.400","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background Gastrointestinal (GI) malignancies account for greater than one-third of cancer-related deaths worldwide. In Zambia, there is a lack of data on epidemiology, diagnosis, management, and outcomes. We sought to review existing literature to determine the extent of research and identify gaps in knowledge pertaining to GI malignancies in Zambia. Methods We systematically searched databases including Ovid MEDLINE, CINAHL, Web of Science Core Collection, Cochrane Library via Ovid, Embase, Africa Wide Information via Ebsco, African Index Medicus and African Journals Online, to identify studies on GI malignancies including colorectal (CRC), pancreatic (PC), gastric (GC), esophageal (EC) and liver cancers (LC) in Zambia.  Results Of 323 studies screened, 27 were included in the final analysis. The included studies assessed an individual GI cancer or more than one GI cancer as follows: GC only (n=10, 37%), EC only (n=5, 18%), LC only (n=5, 18%), CRC only (n=2, 7%), PC only (n=1, 4%), PC, CRC, EC, GC, LC combined (n=1, 4%), CRC, EC, GC, LC combined (n=1, 4%), CRC, EC, GC combined (n=1, 4%) and EC, GC combined (n=1, 4%). Gastric cancer was the most studied (n =14 articles), followed by esophageal (n=9 articles), liver cancer (n=7 articles), colorectal (n=5 articles) and pancreatic cancer (n=2 articles).  Conclusion There is paucity of published data. Existing studies have focused mainly on prevalence and risk factors. Longitudinal studies examining incidence, prognosis and survival are needed.    Keywords: Gastrointestinal cancer, Zambia, risk factors, management, clinical outcomes.  
赞比亚的胃肠道恶性肿瘤:范围界定审查
背景 胃肠道(GI)恶性肿瘤占全球癌症相关死亡人数的三分之一以上。在赞比亚,缺乏有关流行病学、诊断、管理和结果的数据。我们试图对现有文献进行回顾,以确定研究范围,并找出赞比亚消化道恶性肿瘤相关知识的不足之处。方法 我们系统地检索了 Ovid MEDLINE、CINAHL、Web of Science Core Collection、Cochrane Library via Ovid、Embase、Africa Wide Information via Ebsco、African Index Medicus 和 African Journals Online 等数据库,以确定有关赞比亚消化道恶性肿瘤(包括结直肠癌 (CRC)、胰腺癌 (PC)、胃癌 (GC)、食管癌 (EC) 和肝癌 (LC) 的研究。 结果 在筛选出的 323 项研究中,27 项被纳入最终分析。纳入的研究对一种或多种消化道癌症进行了评估,具体情况如下:仅 GC(n=10,37%),仅 EC(n=5,18%),仅 LC(n=5,18%),仅 CRC(n=2,7%),仅 PC(n=1,4%),PC、CRC、EC、GC、LC 合并(n=1,4%),CRC、EC、GC、LC 合并(n=1,4%),CRC、EC、GC 合并(n=1,4%)以及 EC、GC 合并(n=1,4%)。研究最多的是胃癌(n=14 篇文章),其次是食管癌(n=9 篇文章)、肝癌(n=7 篇文章)、结直肠癌(n=5 篇文章)和胰腺癌(n=2 篇文章)。 结论 已发表的数据很少。现有研究主要侧重于发病率和风险因素。需要对发病率、预后和存活率进行纵向研究。 关键词胃肠道癌症、赞比亚、风险因素、管理、临床结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信